The 11th Executive Congress on Translational Medicine, Biotech Innovation & Clinical Strategy supports the responsible dissemination of high-value clinical insights, translational research perspectives, biotech innovation outcomes, and executive strategy discussions. Where available, selected participants may be invited to explore publication-related opportunities aligned with the congress scope.
Publication is optional and separate from registration. Any manuscript remains subject to scope fit, editorial assessment, peer review where applicable, ethics requirements, publisher policies and the final decision of the relevant outlet.
Publication opportunities at ECTMBICS 2027, where available, are designed to extend the value of selected executive discussions, invited thought leadership, translational medicine insights, clinical research perspectives, biotech innovation outcomes, and academically grounded contributions. Availability may vary by session, topic relevance, and editorial alignment.
Participation in the congress does not automatically include publication. Any publication-related opportunity remains subject to invitation, suitability, independent editorial review, ethics requirements, and the requirements of the relevant outlet or format.
Executive Congresses does not guarantee manuscript acceptance, indexing, impact metrics, peer-review outcomes, publication dates, citations, or editorial decisions.
Depending on the research, manuscript maturity, publication arrangements and editorial suitability, authors may consider the following routes where available.
Selected contributors may be invited to develop an extended manuscript based on their congress contribution, clinical strategy case study, keynote, translational medicine topic, or academically mature presentation.
Selected ECTMBICS 2027 submissions may be considered for pathways aligned with the Journal of Clinical Medicine (JCM, MDPI) and Current Medical Science (Springer), depending on scope and manuscript suitability.
Selected non-confidential insights may be distilled into conference research summaries, healthcare innovation briefs, clinical strategy notes, or congress outcome resources intended for strategic dissemination.
The journals below are classified by their strongest fit with the congress scope. Recommendation or referral for journal consideration does not guarantee publication. Each manuscript remains subject to journal scope, editorial screening, independent peer review, ethics requirements, and final editorial decision.
An international, peer-reviewed open-access journal covering broad areas of clinical medicine, including internal medicine, cardiology, oncology, neurology, surgery, clinical epidemiology, diagnostics, therapeutics, and related patient-centred research. Selected ECTMBICS 2027 contributions with strong clinical or translational relevance may be recommended for consideration, subject to editorial screening and peer review.
Visit Journal Page →A peer-reviewed journal publishing advances across clinical and experimental medicine, including diagnostics, therapeutics, disease mechanisms, translational investigation, and clinically relevant biomedical research. Eligible ECTMBICS 2027 manuscripts aligned with the journal's scope may be recommended for consideration, subject to full peer review and editorial decision.
Visit Journal Page →ECTMBICS 2027 / Executive Congresses does not charge a separate publication-support fee for manuscripts considered through the congress-linked journal pathway. Any publisher-side article processing charge (APC), open-access fee, tax, waiver, institutional agreement, or other journal charge is governed independently by the relevant journal or publisher.
Authors of accepted oral, poster, keynote, invited, or other approved scientific contributions may explore suitable publication routes where available. The publication route should be appropriate to the subject, maturity and originality of the work.
A conference abstract and a full journal manuscript are not the same submission. Authors should expand the work appropriately, comply with the target outlet's author instructions, and disclose prior abstract or conference presentation where required.
Conference registration fees relate only to participation in ECTMBICS 2027. The congress does not charge a separate publication-support fee for the conference-linked journal pathway. Any publisher-side APC, open-access fee, tax, or other journal charge, if applicable, is controlled independently by the relevant publisher.
No sponsorship, registration payment, conference participation, or fee arrangement can override an independent editorial or peer-review decision.
Review the publication information and identify whether a journal, extended manuscript, proceedings, or other available route is suitable for your work.
Prepare the manuscript in accordance with the target outlet’s author instructions, scope, formatting, ethics, authorship, disclosure and data requirements.
The relevant journal, publisher, proceedings editor or editorial team assesses the submission for originality, relevance, ethics, quality, clarity and scope fit.
The final outcome may include acceptance, revision, resubmission or rejection. The decision rests with the relevant editorial authority and is independent of conference registration.
All submitted content must be original and must not infringe copyright, intellectual property rights, confidentiality obligations, patient privacy, institutional permissions, or third-party rights.
Executive Congresses does not support plagiarism, duplicate submission, fabricated data, ghostwriting, misleading claims, unethical authorship practices, or inappropriate clinical and research reporting conduct.
Where relevant, contributors may be asked to disclose conflicts of interest, ethics approvals, data permissions, clinical approvals, consent-related documentation, or institutional clearance.
Because ECTMBICS 2027 includes executive, clinical, industry, and institution-facing participation, contributors should avoid including proprietary, confidential, restricted, commercially sensitive, or patient-identifiable information unless expressly cleared for disclosure.
Some executive-level discussions may be suitable only for non-attributable summaries or high-level synthesized outcomes, rather than formal publication.
Publication suitability is therefore assessed not only on quality, but also on disclosure appropriateness, clinical sensitivity, research integrity, and strategic relevance.
No. Publication is optional. Participants may attend or present at ECTMBICS 2027 without submitting a full manuscript.
No. Congress participation and publication consideration are separate processes. Publication-related opportunities remain subject to invitation, editorial suitability, ethics requirements, and review processes.
No. ECTMBICS 2027 / Executive Congresses does not charge a separate publication-support fee for the congress-linked pathway. Any publisher-side APC, open-access fee, tax, or other journal charge, if applicable, remains governed independently by the publisher.
No. These matters depend on the relevant outlet, editorial process, publisher policies, and external policies, and may change over time.
Share your presentation title, research area and preferred publication route, and the conference team can provide available publication information. Final journal suitability and acceptance remain subject to the relevant publisher or editorial process.